Clinical Trials Browser

Not yet recruiting × OTHER × Myeloproliferative Disorders × Clear all

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

NCT07518940 2026-04-09

ENERGIA

Motor Activity, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT05969821 2026-03-23

CHIS

Not yet recruiting

5,000 enrolled

LymphoidMyeloidOther hematologic neoplasm

VEXAS syndrome, Autoimmune Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Leukemia, Lymphoma, Lymphoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT07387354 2026-03-16

MDS

Phase 1/2 Not yet recruiting

25 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT07468916 2026-03-13

Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia

Phase 2 Not yet recruiting

35 enrolled

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Thrombocytosis, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT07384039 2026-02-05

MPN-Exercise

Phase NA Not yet recruiting

80 enrolled

Myeloid

Myeloproliferative Disorders

NCT07379125 2026-01-30

Therapeutic RSK1 Targeting in Myelofibrosis

Phase 1 Not yet recruiting

18 enrolled

Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT07349134 2026-01-20

WELL-MPN

Phase NA Not yet recruiting

75 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07249840 2025-11-25

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Phase 1 Not yet recruiting

12 enrolled

Myeloid

Myeloproliferative Disorders

NCT07108023 2025-08-06

EHPVO-HEM

Not yet recruiting

115 enrolled

Classical hematologyMyeloid

Anemia, Hematologic Diseases, Hemoglobinuria, Paroxysmal, Hypersplenism, Leukopenia, Myeloproliferative Disorders, Thrombocytopenia, Antiphospholipid Syndrome, Thrombophilia

NCT06753279 2024-12-31